Preclinical activity of the novel B‐cell‐specific Moloney murine leukemia virus integration site 1 inhibitor <scp>PTC</scp>‐209 in acute myeloid leukemia: Implications for leukemia therapy
Yuki Nishida(Saga University), Kensuke Kojima(Kōchi University)
Cited by 27
Related Papers
The novel BMI-1 inhibitor PTC596 downregulates MCL-1 and induces p53-independent mitochondrial apoptosis in acute myeloid leukemia progenitor cells
|Blood Cancer Journal|2017|105
The pathophysiological significance of PPM1D and therapeutic targeting of PPM1D-mediated signaling by GSK2830371 in mantle cell lymphoma
|Oncotarget|2016|13